Previous Close | 0.9980 |
Open | 0.9480 |
Bid | 0.9640 x N/A |
Ask | 1.0150 x N/A |
Day's Range | 0.9480 - 0.9580 |
52 Week Range | 0.8960 - 1.1560 |
Volume | |
Avg. Volume | 1,148 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for P4T.MU
Toronto, Ontario--(Newsfile Corp. - January 27, 2023) - Cybeats Technologies Corp. (CSE: CYBT) ("Cybeats'' or the "Company") is pleased to report that after the signing of recent commercial contracts, 75% of all organizations that have completed SBOM Studio1 pilot evaluation periods have moved on to sign commercial licence agreements with the Company.SBOM Studio is defining and pioneering the future of automated SBOM management, helping organizations proactively improve visibility and security a
Cybeats Technologies Corp. ("Cybeats'' or the "Company") (CSE: CYBT) is pleased to announce the signing of a three-year software licence agreement for Cybeats SBOM Studio1 with a global leader in building technology and industrial automation, to manage their Software Bill of Materials (SBOM) and improve security across the software supply chain.
Cybeats Technologies Corp. ("Cybeats'' or the "Company") (CSE: CYBT) is pleased to announce a new software licence agreement with a top 3 global medical device and diagnostics leader, for Cybeats' SBOM Studio1, to manage their Software Bill of Materials (SBOM) and support regulatory compliance requirements with looming FDA mandates on SBOM adoption for medical device manufacturers.2